Sales news

Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI(R) Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)

External page is loading, the page should display in a few seconds..

    Follow @newslocke_sales on Twitter!